Vulnerability Details : CVE-2022-43575
IBM Aspera Console 3.4.0 through 3.4.2 PL5 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 238645.
Vulnerability category: Cross site scripting (XSS)
Products affected by CVE-2022-43575
- cpe:2.3:a:ibm:aspera_console:*:*:*:*:*:*:*:*
- cpe:2.3:a:ibm:aspera_console:*:*:*:*:*:*:*:*
- cpe:2.3:a:ibm:aspera_console:3.4.2:patch_level_4:*:*:*:*:*:*
- cpe:2.3:a:ibm:aspera_console:3.4.2:patch_level_5:*:*:*:*:*:*
- cpe:2.3:a:ibm:aspera_console:3.4.2:patch_level_2:*:*:*:*:*:*
- cpe:2.3:a:ibm:aspera_console:3.4.2:patch_level_3:*:*:*:*:*:*
- cpe:2.3:a:ibm:aspera_console:3.4.2:patch_level_1:*:*:*:*:*:*
Exploit prediction scoring system (EPSS) score for CVE-2022-43575
0.05%
Probability of exploitation activity in the next 30 days
EPSS Score History
~ 12 %
Percentile, the proportion of vulnerabilities that are scored at or less
CVSS scores for CVE-2022-43575
Base Score | Base Severity | CVSS Vector | Exploitability Score | Impact Score | Score Source | First Seen |
---|---|---|---|---|---|---|
5.4
|
MEDIUM | CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N |
N/A
|
N/A
|
IBM Corporation | 2024-05-30 |
5.4
|
MEDIUM | CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N |
2.3
|
2.7
|
NIST | 2025-01-08 |
5.4
|
MEDIUM | CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N |
2.3
|
2.7
|
IBM Corporation | 2024-05-30 |
CWE ids for CVE-2022-43575
-
The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users.Assigned by:
- 9a959283-ebb5-44b6-b705-dcc2bbced522 (Primary)
- psirt@us.ibm.com (Secondary)
References for CVE-2022-43575
-
https://exchange.xforce.ibmcloud.com/vulnerabilities/238680
IBM Aspera Console cross-site scripting CVE-2022-43575 Vulnerability ReportVendor Advisory
-
https://www.ibm.com/support/pages/node/7155215
Vendor Advisory
Jump to